Literature DB >> 23476721

Alterations in "in vivo" histology of retina in bilateral chronic central serous chorioretinopathy after intravitreal bevacizumab.

Sandeep Saxena1, Astha Jain.   

Abstract

Entities:  

Year:  2012        PMID： 23476721      PMCID： PMC3389553          DOI： 10.1007/s12177-012-9077-y

Source DB:  PubMed          Journal:  J Ocul Biol Dis Infor        ISSN： 1936-8437


× No keyword cloud information.
  21 in total

1.  Evaluation of central serous chorioretinopathy with optical coherence tomography.

Authors:  T Iida; N Hagimura; T Sato; S Kishi
Journal:  Am J Ophthalmol       Date:  2000-01       Impact factor: 5.258

2.  Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy.

Authors:  W-C Huang; W-L Chen; Y-Y Tsai; C-C Chiang; J-M Lin
Journal:  Eye (Lond)       Date:  2008-03-14       Impact factor: 3.775

3.  The treatment of recurrent central serous chorioretinopathy with intravitreal bevacizumab.

Authors:  Shelly T Lee; Ron A Adelman
Journal:  J Ocul Pharmacol Ther       Date:  2011-08-02       Impact factor: 2.671

4.  Choroidal neovascularization and central serous chorioretinopathy.

Authors:  J E Gomolin
Journal:  Can J Ophthalmol       Date:  1989-02       Impact factor: 1.882

5.  The foveal photoreceptor layer and visual acuity loss in central serous chorioretinopathy.

Authors:  Felice Cardillo Piccolino; Roberta Rigault de la Longrais; Giambattista Ravera; Chiara M Eandi; Luca Ventre; Ali' Abdollahi; Marilisa Manea
Journal:  Am J Ophthalmol       Date:  2005-01       Impact factor: 5.258

6.  Apoptotic photoreceptor degeneration in experimental retinal detachment.

Authors:  B Cook; G P Lewis; S K Fisher; R Adler
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-05       Impact factor: 4.799

7.  Long-term follow-up of central serous chorioretinopathy.

Authors:  C M Gilbert; S L Owens; P D Smith; S L Fine
Journal:  Br J Ophthalmol       Date:  1984-11       Impact factor: 4.638

8.  Cystoid macular degeneration in chronic central serous chorioretinopathy.

Authors:  Tomohiro Iida; Lawrence A Yannuzzi; Richard F Spaide; Natalie Borodoker; Cynthia A Carvalho; Silvana Negrao
Journal:  Retina       Date:  2003-02       Impact factor: 4.256

9.  Intravitreal bevacizumab for treatment of chronic central serous chorioretinopathy.

Authors:  Karen B Schaal; Alexandra E Hoeh; Alexander Scheuerle; Florian Schuett; Stefan Dithmar
Journal:  Eur J Ophthalmol       Date:  2009 Jul-Aug       Impact factor: 2.597

10.  Renewal of fatty acids in the membranes of visual cell outer segments.

Authors:  C Bibb; R W Young
Journal:  J Cell Biol       Date:  1974-05       Impact factor: 10.539
View more
  1 in total

Review 1.  Photoreceptor inner segment ellipsoid band integrity on spectral domain optical coherence tomography.

Authors:  Sandeep Saxena; Khushboo Srivastav; Chui M Cheung; Joanne Yw Ng; Timothy Yy Lai
Journal:  Clin Ophthalmol       Date:  2014-12-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.